Read More Healthcare Industry News Memphasys (ASX:MEM) wins UK IVF orders, but cartridge demand must prove the model Memphasys has secured first UK Felix orders as ASX:MEM rallies. The test is whether clinic trials convert into recurring cartridge revenue at scale. byVenkateshJune 26, 2026